Global Next-Generation Sequencing (NGS) Services 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR012505218

Publication Date:

January 15, 2025

Pages:

110

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Next-Generation Sequencing (NGS) Services market size was valued at US$ 4431 million in 2024 and is forecast to a readjusted size of USD 11690 million by 2031 with a CAGR of 15.0% during review period.
Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.
The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.
Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.
North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.
Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.
This report is a detailed and comprehensive analysis for global Next-Generation Sequencing (NGS) Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Next-Generation Sequencing (NGS) Services market size and forecasts, in consumption value ($ Million), 2020-2031
Global Next-Generation Sequencing (NGS) Services market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Next-Generation Sequencing (NGS) Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Next-Generation Sequencing (NGS) Services market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Next-Generation Sequencing (NGS) Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Next-Generation Sequencing (NGS) Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Personalis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Next-Generation Sequencing (NGS) Services market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
麻豆原创 segment by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
麻豆原创 segment by players, this report covers
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Next-Generation Sequencing (NGS) Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Next-Generation Sequencing (NGS) Services, with revenue, gross margin, and global market share of Next-Generation Sequencing (NGS) Services from 2020 to 2025.
Chapter 3, the Next-Generation Sequencing (NGS) Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Next-Generation Sequencing (NGS) Services market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Next-Generation Sequencing (NGS) Services.
Chapter 13, to describe Next-Generation Sequencing (NGS) Services research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Next-Generation Sequencing (NGS) Services by Type
1.3.1 Overview: Global Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Next-Generation Sequencing (NGS) Services Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Targeted Sequencing
1.3.4 Whole Exome Sequencing
1.3.5 Whole Genome Sequencing
1.4 Global Next-Generation Sequencing (NGS) Services 麻豆原创 by Application
1.4.1 Overview: Global Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals and Clinics
1.4.3 Biopharma Companies
1.4.4 Academic & Research Organizations
1.4.5 Others
1.5 Global Next-Generation Sequencing (NGS) Services 麻豆原创 Size & Forecast
1.6 Global Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast by Region
1.6.1 Global Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Eurofins Scientific
2.1.1 Eurofins Scientific Details
2.1.2 Eurofins Scientific Major Business
2.1.3 Eurofins Scientific Next-Generation Sequencing (NGS) Services Product and Solutions
2.1.4 Eurofins Scientific Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Eurofins Scientific Recent Developments and Future Plans
2.2 Natera
2.2.1 Natera Details
2.2.2 Natera Major Business
2.2.3 Natera Next-Generation Sequencing (NGS) Services Product and Solutions
2.2.4 Natera Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Natera Recent Developments and Future Plans
2.3 BGI
2.3.1 BGI Details
2.3.2 BGI Major Business
2.3.3 BGI Next-Generation Sequencing (NGS) Services Product and Solutions
2.3.4 BGI Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 BGI Recent Developments and Future Plans
2.4 Illumina
2.4.1 Illumina Details
2.4.2 Illumina Major Business
2.4.3 Illumina Next-Generation Sequencing (NGS) Services Product and Solutions
2.4.4 Illumina Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Illumina Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Next-Generation Sequencing (NGS) Services Product and Solutions
2.5.4 Roche Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Roche Recent Developments and Future Plans
2.6 LabCorp
2.6.1 LabCorp Details
2.6.2 LabCorp Major Business
2.6.3 LabCorp Next-Generation Sequencing (NGS) Services Product and Solutions
2.6.4 LabCorp Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 LabCorp Recent Developments and Future Plans
2.7 Berry Genomics
2.7.1 Berry Genomics Details
2.7.2 Berry Genomics Major Business
2.7.3 Berry Genomics Next-Generation Sequencing (NGS) Services Product and Solutions
2.7.4 Berry Genomics Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Berry Genomics Recent Developments and Future Plans
2.8 Brooks Life Sciences
2.8.1 Brooks Life Sciences Details
2.8.2 Brooks Life Sciences Major Business
2.8.3 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Product and Solutions
2.8.4 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Brooks Life Sciences Recent Developments and Future Plans
2.9 Macrogen
2.9.1 Macrogen Details
2.9.2 Macrogen Major Business
2.9.3 Macrogen Next-Generation Sequencing (NGS) Services Product and Solutions
2.9.4 Macrogen Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Macrogen Recent Developments and Future Plans
2.10 Personalis
2.10.1 Personalis Details
2.10.2 Personalis Major Business
2.10.3 Personalis Next-Generation Sequencing (NGS) Services Product and Solutions
2.10.4 Personalis Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Personalis Recent Developments and Future Plans
2.11 Novogene
2.11.1 Novogene Details
2.11.2 Novogene Major Business
2.11.3 Novogene Next-Generation Sequencing (NGS) Services Product and Solutions
2.11.4 Novogene Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Novogene Recent Developments and Future Plans
2.12 Genotypic Technology
2.12.1 Genotypic Technology Details
2.12.2 Genotypic Technology Major Business
2.12.3 Genotypic Technology Next-Generation Sequencing (NGS) Services Product and Solutions
2.12.4 Genotypic Technology Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Genotypic Technology Recent Developments and Future Plans
2.13 Dna Link
2.13.1 Dna Link Details
2.13.2 Dna Link Major Business
2.13.3 Dna Link Next-Generation Sequencing (NGS) Services Product and Solutions
2.13.4 Dna Link Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Dna Link Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Next-Generation Sequencing (NGS) Services Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Next-Generation Sequencing (NGS) Services by Company Revenue
3.2.2 Top 3 Next-Generation Sequencing (NGS) Services Players 麻豆原创 Share in 2024
3.2.3 Top 6 Next-Generation Sequencing (NGS) Services Players 麻豆原创 Share in 2024
3.3 Next-Generation Sequencing (NGS) Services 麻豆原创: Overall Company Footprint Analysis
3.3.1 Next-Generation Sequencing (NGS) Services 麻豆原创: Region Footprint
3.3.2 Next-Generation Sequencing (NGS) Services 麻豆原创: Company Product Type Footprint
3.3.3 Next-Generation Sequencing (NGS) Services 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Next-Generation Sequencing (NGS) Services Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Next-Generation Sequencing (NGS) Services 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Next-Generation Sequencing (NGS) Services Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Next-Generation Sequencing (NGS) Services 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Next-Generation Sequencing (NGS) Services Consumption Value by Type (2020-2031)
6.2 North America Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Application (2020-2031)
6.3 North America Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Country
6.3.1 North America Next-Generation Sequencing (NGS) Services Consumption Value by Country (2020-2031)
6.3.2 United States Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Next-Generation Sequencing (NGS) Services Consumption Value by Type (2020-2031)
7.2 Europe Next-Generation Sequencing (NGS) Services Consumption Value by Application (2020-2031)
7.3 Europe Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Country
7.3.1 Europe Next-Generation Sequencing (NGS) Services Consumption Value by Country (2020-2031)
7.3.2 Germany Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Region
8.3.1 Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value by Region (2020-2031)
8.3.2 China Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Next-Generation Sequencing (NGS) Services Consumption Value by Type (2020-2031)
9.2 South America Next-Generation Sequencing (NGS) Services Consumption Value by Application (2020-2031)
9.3 South America Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Country
9.3.1 South America Next-Generation Sequencing (NGS) Services Consumption Value by Country (2020-2031)
9.3.2 Brazil Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Next-Generation Sequencing (NGS) Services Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Next-Generation Sequencing (NGS) Services Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Country
10.3.1 Middle East & Africa Next-Generation Sequencing (NGS) Services Consumption Value by Country (2020-2031)
10.3.2 Turkey Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Next-Generation Sequencing (NGS) Services 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Next-Generation Sequencing (NGS) Services 麻豆原创 Drivers
11.2 Next-Generation Sequencing (NGS) Services 麻豆原创 Restraints
11.3 Next-Generation Sequencing (NGS) Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Next-Generation Sequencing (NGS) Services Industry Chain
12.2 Next-Generation Sequencing (NGS) Services Upstream Analysis
12.3 Next-Generation Sequencing (NGS) Services Midstream Analysis
12.4 Next-Generation Sequencing (NGS) Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.